Drug-Eluting and Bare-Metal Stents Both Safe in Large Arteries

Patients with drug-eluting stents also have lower rates of revascularization.

When a large coronary artery becomes narrowed due to plaque build-up, a drug-eluting stent (DES) is just as safe as a bare-metal stent (BMS) for opening a narrowed vessel, according to a large study presented at the 2010 American Heart Associations Scientific Sessions. Patients with DES and BMS had similar rates of deaths and heart attacks. The study compared the safety and effectiveness of three types of stent: bare-metal stents, stents that eluted the drug sirolimus and those that eluted the drug everolimus.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access